Does a product (dry powder inhaler device) need to be CE-marked to be dispensed in a clinical trial in the EU or UK? The model we are going to be dispensing in the study is currently not CE marked. Can this be used in the UK and EU? There is an earlier version of the product that is CE marked under MDD which is identical in every way except for the non-product contact part which is the protective cap.